AI can determine eczema severity from images, with results correlating with severity assigned by board-certified clinicians.

A new COVID-19 variant, NB.1.8.1, has spread in the Mediterranean, Southeast Asia, and Western Pacific regions.

The FDA has announced its plan for systematically reviewing food additives already commercially available for the first time.

Female primary care physicians received worse average provider rating scores than men despite their patients having better hemoglobin A1c control, eye examination receipt, and composite quality scores ...

Integrating a therapist into the nursing team of an intensive care unit improves nurses' job satisfaction, burnout, and resiliency.

Most clinicians see adolescents with substance use disorders monthly, while about half report screening for them at every visit.

Treatment with guselkumab among patients with psoriasis does not contribute to the risk for or progression of liver fibrosis.

Patients with psoriasis generally prefer the standard of care over teledermatology, but certain attributes change patient preferences.

US News & World Report has released its new over-the-counter (OTC) medicine and health product rankings for 2025.

Symptoms, lesion locations, and morphology are among the features clinicians may use to distinguish hand eczema from hand psoriasis in patients.

Rilzabrutinib is a promising treatment option for patients with chronic spontaneous urticaria who are refractory to antihistamines.

Those who are not considered "high risk" will be ineligible for future COVID-19 booster vaccines that have not undergone extra testing.